FDA clears Koios DS Breast 2.0 to assist physicians with AI-based software
advertisement
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Health IT Homepage

Margaret West Comprehensive Breast Center selects Ikonopedia for structured breast reporting and risk assessment

Healthcare IT solutions provider, Comport explains the benefits of cloud object storage for healthcare

Holon Solutions awarded second U.S. patent this year targeted at solving healthcare interoperability

DrChrono and OutcomeMD announce partnership making it easier to track and analyze patient outcome data and confounding factors

Study of top U.S. health systems finds patient billing and revenue cycle management improvement, but multiple challenges ahead

The SyMRI NEURO software from SyntheticMR AB now available on syngo.via open apps from Siemens Healthineers in U.S.

NetDirector cloud-based PDF to DICOM conversion is live with American Health Imaging and continues to expand

CynergisTek sees increased demand for medical device security services in first year of deployment

Kent Diagnostic Radiology contracts with Healthcare Administrative Partners for comprehensive revenue cycle services

DrFirst integrates mobile device access to enable fast, seamless single sign-on to Backline

FDA clears Koios DS Breast 2.0 to assist physicians with AI-based software

Press releases may be edited for formatting or style
CHICAGO, July 9, 2019 /PRNewswire/ -- Koios Medical, the leader in ultrasound diagnosis decision support software, announces its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Koios DS (Decision Support) Breast 2.0 is intended for use to assist physicians analyzing breast ultrasound images and aligns a machine learning generated probability of malignancy with the appropriate BI-RADS category.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



This milestone is an important step in advancing the company's mission of empowering physicians to improve diagnostic accuracy. Now cleared for use at the point of care (or connected to an image viewer for studies stored on PACS), Koios Medical's advancements represent a huge leap forward in using artificial intelligence in healthcare by bringing the power of deep learning to physicians' fingertips. Koios DS Breast 2.0 represents the most advanced AI-based diagnostic technology for ultrasound image analysis to date. This patented software uses an ensemble of algorithms to aid the early detection of disease while also reducing biopsies of benign tissue.

In a recent reader study involving 15 physicians with relevant experience up to 39 years, each randomly analyzed 900 cases twice, separated by a one-month "washout period." Physicians utilizing the Koios DS 2.0 AI software experienced a statistically significant improvement in accuracy as measured by area under the ROC (receiver operating characteristic) curve (AUC), while simultaneously reducing both inter and intra-operator variability.

"We are seeing the promise of machine learning as a physician's assistant coming to fruition. This will undoubtedly improve quality, outcomes, and patient experiences—and ultimately save lives. Koios DS Breast 2.0 is proving that a system trained by hundreds of thousands of images linked to their ground truth can catch many more cancers earlier, while simultaneously reducing benign biopsies and all the anxiety, complications, and associated expense. Smart ultrasound is a second set of eyes that achieves what was previously unthinkable," says Koios Medical CEO Chad McClennan.

Koios DS Breast 2.0 can be used in conjunction with most major PACS platforms and is directly available on the LOGIQTM E10, GE Healthcare's next generation digital ultrasound system that integrates artificial intelligence, cloud connectivity, and advanced algorithms to acquire and reconstruct data. Machine generated results can be exported directly into a patient's record. Koios Medical continues to experiment with thyroid ultrasound image data and expects to add to its offering later this year.


About Koios Medical:
Koios Medical develops medical software to assist physicians interpreting ultrasound images and applies deep learning methods to the process of reaching an accurate diagnosis. The Koios DS platform uses advanced algorithms to assist in the early detection of disease while reducing recommendations for biopsy of benign tissue. Patented technology saves physicians time, helps improve patient outcomes, and reduces healthcare costs. Koios DS Breast is presently focused on breast cancer diagnosis assistance market. Women with dense breast tissue (over 40% in the US) often require an alternative to mammography for diagnosis. Ultrasound is a widely available and effective alternative to mammography with no radiation and is standard of care for breast cancer diagnosis.


SOURCE Koios Medical

Health IT Homepage


You Must Be Logged In To Post A Comment